SpringWorks Therapeutics Inc. (SWTX) options active on 61K contracts
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500 volatile in choppy trading; Mideast deal, SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Barclays Downgrades Spring Works Therapeutics (SWTX) to Equalweight
April 28, 2025 9:29 AM EDTBarclays analyst Peter Lawson downgraded Spring Works Therapeutics (NASDAQ: SWTX) from Overweight to Equalweight with a price target of $47.00 (from $63.00).
For an analyst ratings summary and ratings history on Spring Works Therapeutics... More
